Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RAF1 | P04049 | 3/20 | 0.32 |
| ▸ | BRAF | P15056 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KCNJ5 | P48544 | 4/20 | 0.31 |
| ▸ | KCNJ3 | P48549 | 4/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21601348 | 0.85 | S1PR4 (0.35) | SCN9ARAF1BRAFKCNJ5KCNJ3 | |
| SCHEMBL21601140 | 0.83 | KCNH2 (0.34) | RAF1BRAFGRIN2B | |
| SCHEMBL20372152 | 0.82 | PIK3CA (0.32) | — | |
| SCHEMBL21601406 | 0.81 | KCNH2 (0.47) | SCN9APOLB | |
| SCHEMBL20372597 | 0.81 | KCNH2 (0.36) | RAF1BRAF | |
| SCHEMBL20372314 | 0.81 | KCNH2 (0.37) | GRIN2B | |
| SCHEMBL20372396 | 0.79 | KCNH2 (0.36) | — | |
| SCHEMBL20372542 | 0.79 | KCNH2 (0.36) | SCN9ARAF1BRAFKCNJ5KCNJ3 | |
| SCHEMBL21601253 | 0.79 | KCNH2 (0.42) | — | |
| SCHEMBL20371993 | 0.78 | SLC22A12 (0.36) | MAPTRAF1BRAFGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019244066-A2 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2019-12-26 | — | — | WO | disclosed |